Science Explorer Back to mapMap
Discussion
Company · Paterna · Spain

Highlight Therapeutics (Spain)

bioncotech.comROR OpenAlex
Research works
20
▲ 30% vs 2018-21
Citations
197
10.1 per fractional work
Top-10% rate
8.1%
all institutions 10.0%
Open access
49%
world 40%
International
40%
world 18%
Highlight Therapeutics (Spain)

Not ranked overall: Highlight Therapeutics (Spain) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Highlight Therapeutics (Spain) work in?

In all years, 45% of research at Highlight Therapeutics (Spain) is in Health Sciences, 40% in Life Sciences. Its largest fields are Medicine (35%), Biochemistry, Genetics and Molecular Biology (29%), Dentistry (10%). It does 1.8× the world's share of Life Sciences.

Health Sciences: 9 fractional works · 44.8% of its workMedicine: 7 fractional works · 34.5% of its workOncology: 2 fractional works · 10.2% of its workPulmonary and Respiratory Medicine: 1 fractional works · 4.3% of its workPhysiology: 1 fractional works · 3.4% of its workCardiology and Cardiovascular Medicine: 1 fractional works · 2.9% of its workRadiology, Nuclear Medicine and Imaging: 1 fractional works · 2.7% of its workSurgery: 0 fractional works · 1.9% of its workPublic Health, Environmental and Occupational Health: 0 fractional works · 1.8% of its workInfectious Diseases: 0 fractional works · 1.1% of its workNeurology: 0 fractional works · 0.9% of its workDermatology: 0 fractional works · 0.9% of its workImmunology and Allergy: 0 fractional works · 0.9% of its workEndocrinology, Diabetes and Metabolism: 0 fractional works · 0.6% of its workEpidemiology: 0 fractional works · 0.6% of its workNephrology: 0 fractional works · 0.5% of its workPathology and Forensic Medicine: 0 fractional works · 0.5% of its workHepatology: 0 fractional works · 0.4% of its workGastroenterology: 0 fractional works · 0.3% of its workObstetrics and Gynecology: 0 fractional works · 0.3% of its workReproductive Medicine: 0 fractional works · 0.3% of its workPharmacology: 0 fractional works · 0.2% of its workDentistry: 2 fractional works · 10.2% of its workOral Surgery: 1 fractional works · 5.4% of its workOrthodontics: 1 fractional works · 4.8% of its workLife Sciences: 8 fractional works · 40.0% of its workBiochemistry, Genetics and Molecular Biology: 6 fractional works · 29.2% of its workMolecular Biology: 4 fractional works · 21.0% of its workCell Biology: 0 fractional works · 2.5% of its workGenetics: 0 fractional works · 2.3% of its workBiotechnology: 0 fractional works · 1.8% of its workCancer Research: 0 fractional works · 1.1% of its workMolecular Medicine: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.2% of its workImmunology and Microbiology: 2 fractional works · 9.9% of its workImmunology: 2 fractional works · 9.6% of its workVirology: 0 fractional works · 0.4% of its workNeuroscience: 0 fractional works · 0.7% of its workCellular and Molecular Neuroscience: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.3% of its workAgricultural and Biological Sciences: 0 fractional works · 0.3% of its workPlant Science: 0 fractional works · 0.3% of its workPhysical Sciences: 2 fractional works · 10.1% of its workEngineering: 1 fractional works · 3.7% of its workBiomedical Engineering: 0 fractional works · 2.5% of its workOcean Engineering: 0 fractional works · 0.9% of its workElectrical and Electronic Engineering: 0 fractional works · 0.4% of its workChemistry: 0 fractional works · 1.8% of its workOrganic Chemistry: 0 fractional works · 1.8% of its workMathematics: 0 fractional works · 1.7% of its workStatistics and Probability: 0 fractional works · 1.7% of its workEnvironmental Science: 0 fractional works · 1.0% of its workEnvironmental Engineering: 0 fractional works · 0.9% of its workSmaller subfields together: 0 fractional works · 0.2% of its workMaterials Science: 0 fractional works · 1.0% of its workBiomaterials: 0 fractional works · 0.9% of its workSmaller subfields together: 0 fractional works · 0.1% of its workEarth and Planetary Sciences: 0 fractional works · 0.9% of its workGeology: 0 fractional works · 0.9% of its workSocial Sciences: 1 fractional works · 5.1% of its workDecision Sciences: 1 fractional works · 3.4% of its workInformation Systems and Management: 0 fractional works · 1.7% of its workStatistics, Probability and Uncertainty: 0 fractional works · 1.7% of its workSmaller subfields together: 0 fractional works · 0.1% of its workSocial Sciences: 0 fractional works · 1.7% of its workSociology and Political Science: 0 fractional works · 1.7% of its workALL ITS WORKHighlightTherapeutics…20fractional works, all years
Life Sciences40%Physical Sciences10%Health Sciences45%Social Sciences5%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 14 fields, with their numbers
    1. Medicine734.5%
    2. Dentistry210.2%
    1. Biochemistry, Genetics and Molecular Biology629.2%
    2. Immunology and Microbiology29.9%
    3. Neuroscience00.7%
    4. Agricultural and Biological Sciences00.3%
    1. Engineering13.7%
    2. Chemistry01.8%
    3. Mathematics01.7%
    4. Environmental Science01.0%
    5. Materials Science01.0%
    6. Earth and Planetary Sciences00.9%
    1. Decision Sciences13.4%
    2. Social Sciences01.7%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.12× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 4.80× its world share, 3 worksBiochemistry, Geneti…Immunology and Microbiology: 11.24× its world share, 1 worksImmunology and Micro…Neuroscience: 0.46× its world share, 0 worksNeuroscienceEarth and Planetary Sciences: 1.06× its world share, 0 worksEarth and Planetary …Engineering: 0.34× its world share, 0 worksEngineeringEnvironmental Science: 0.40× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.07× its world share, 0 worksMaterials ScienceMathematics: 2.83× its world share, 0 worksMathematicsMedicine: 2.06× its world share, 4 worksMedicineDecision Sciences: 6.88× its world share, 1 worksDecision SciencesSocial Sciences: 0.26× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 11.2×. Every wedge is a field page.

All 12 fields, with their numbers
  1. Immunology and Microbiology11.24×1 works
  2. Decision Sciences6.88×1 works
  3. Biochemistry, Genetics and Molecular Biology4.80×3 works
  4. Mathematics2.83×0 works
  5. Medicine2.06×4 works
  6. Earth and Planetary Sciences1.06×0 works
  7. Neuroscience0.46×0 works
  8. Environmental Science0.40×0 works
  9. Engineering0.34×0 works
  10. Social Sciences0.26×0 works
  11. Agricultural and Biological Sciences0.12×0 works
  12. Materials Science0.07×0 works

Who are the top researchers at Highlight Therapeutics (Spain)?

Ranked on the quality score, Marisol Quintero lead among researchers whose main affiliation is Highlight Therapeutics (Spain).

  1. 1 Marisol Quintero Spain · #932,736 worldwide 1.9k citations · 52 works
All ranked researchers at Highlight Therapeutics (Spain)

What are the most cited papers from Highlight Therapeutics (Spain)?

The most cited paper from Highlight Therapeutics (Spain) is "Starting the fight in the tumor: expert recommendations for the development of human intratumoral immunotherapy (HIT-IT)" (Aurélien Marabelle et al., 2018), with 216 citations. Next come "Evaluating the Efficiency of Hyaluronic Acid for Tumor Targeting via CD44" (145) and "Uncoupling interferon signaling and antigen presentation to overcome immunotherapy resistance due to JAK1 loss in melanoma" (138).

Most cited papers
#PaperReleasedCitations
1 Starting the fight in the tumor: expert recommendations for the development of human intratumoral immunotherapy (HIT-IT) Aurélien Marabelle et al. · Annals of Oncology Open access 6 Oct 2018 216
2 Evaluating the Efficiency of Hyaluronic Acid for Tumor Targeting via CD44 Alice Spadea, Julio M. Rios De La Rosa, Annalisa Tirella et al. · Molecular Pharmaceutics 23 Apr 2019 145
3 Uncoupling interferon signaling and antigen presentation to overcome immunotherapy resistance due to JAK1 loss in melanoma Anusha K. Kalbasi, Mito Tariveranmoshabad, Kevin N. Hakimi et al. · Science Translational Medicine Open access 14 Oct 2020 138
4 Immunotherapeutic effects of intratumoral nanoplexed poly I:C Maria Angela Aznar, Lourdes Planelles, Mercedes Pérez‐Olivares et al. · Journal for ImmunoTherapy of Cancer Open access 2 May 2019 134
5 Inhibition of RANK signaling in breast cancer induces an anti-tumor immune response orchestrated by CD8+ T cells Clara Gomez‐Aleza et al. · Nature Communications Open access 10 Dec 2020 93
All 39 most cited papers, with filters and sorting

Which research topics does Highlight Therapeutics (Spain) publish most on?

By volume in 2022-now: Immunotherapy and Immune Responses, Mosquito-borne diseases and control, Conferences and Exhibitions Management and Lysosomal Storage Disorders Research.

Immunotherapy and Immune…0Immunotherapy and Immune Responses: 0 fractional worksMosquito-borne diseases …0Mosquito-borne diseases and control: 0 fractional worksConferences and Exhibitions Management: 0 fractional worksLysosomal Storage Disorders Research: 0 fractional worksPulmonary Hypertension Research and Treatments: 0 fractional worksEffects of Radiation Exposure: 0 fractional worksCardiac electrophysiology and arrhythmias: 0 fractional worksAcademic Publishing and …0Academic Publishing and Open Access: 0 fractional worksRNA regulation and disease: 0 fractional worksStatistical Methods in Clinical Trials: 0 fractional works
ImmunologyPublic Health, Environmental and Occupational HealthSociology and Political SciencePhysiology6 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Immunotherapy and Immune Responses Immunology 0 works
  2. 2 Mosquito-borne diseases and control Public Health, Environmental and Occupational Health 0 works
  3. 3 Conferences and Exhibitions Management Sociology and Political Science 0 works
  4. 4 Lysosomal Storage Disorders Research Physiology 0 works
  5. 5 Pulmonary Hypertension Research and Treatments Pulmonary and Respiratory Medicine 0 works
  6. 6 Effects of Radiation Exposure Radiology, Nuclear Medicine and Imaging 0 works
  7. 7 Cardiac electrophysiology and arrhythmias Cardiology and Cardiovascular Medicine 0 works
  8. 8 Academic Publishing and Open Access Information Systems and Management 0 works
  9. 9 RNA regulation and disease Molecular Biology 0 works
  10. 10 Statistical Methods in Clinical Trials Statistics and Probability 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available48.7%not open51.3%

World: 40% of research is openly available.

with international co-authors40.2%domestic only59.8%

World: 18% is written across borders.

How has Highlight Therapeutics (Spain)'s research output changed?

Output in 2022-2025 was 30% higher than in 2018-2021.

still counting200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Highlight Therapeutics (Spain) as a percentage of every work published that year, 0.000024% in 2024.

still counting0.000050%0.00010%0.00015%Highlight Therapeutics (Spain)0.000019% in 2025200020102020

Fractional works of Highlight Therapeutics (Spain) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Paterna

All research institutions in Paterna

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Highlight Therapeutics (Spain). Posts are plain text and can be reported.